Resumes
Resumes
Chuanxi Cai Phones & Addresses
-
Glen Allen, VA
-
1054 Carriage Valley Dr, Powell, OH 43065
-
Delmar, NY
-
Guilderland, NY
-
Louisville, KY
-
Fords, NJ
-
Highland Park, NJ
Publications
Us Patents
Prevention And Treatment Of Viral Infection And Viral Infection-Induced Organ Failure
View pageUS Patent:
20210315968, Oct 14, 2021
Filed:
Feb 25, 2021
Appl. No.:
17/184781
Inventors:
- Columbus OH, US
JACOB S. YOUNT - COLUMBUS OH, US
MATTHEW A. SERMERSHEIM - NASHVILLE TN, US
ADAM D. KENNEY - COLUMBUS OH, US
Xinyu ZHOU - HILLIARD OH, US
BRYAN A. WHITSON - WESTERVILLE OH, US
NAHUSH A. MOKADAM - UPPER ARLINGTON OH, US
TAO TAN - COLUMBUS OH, US
CHUANXI CAI - POWELL OH, US
JACOB S. YOUNT - COLUMBUS OH, US
MATTHEW A. SERMERSHEIM - NASHVILLE TN, US
ADAM D. KENNEY - COLUMBUS OH, US
Xinyu ZHOU - HILLIARD OH, US
BRYAN A. WHITSON - WESTERVILLE OH, US
NAHUSH A. MOKADAM - UPPER ARLINGTON OH, US
TAO TAN - COLUMBUS OH, US
CHUANXI CAI - POWELL OH, US
Assignee:
OHIO STATE INNOVATION FOUNDATION - COLUMBUS OH
International Classification:
A61K 38/17
A61K 45/06
A61K 45/06
Abstract:
Compositions for and methods of preventing, reversing or treating viral infection-induced organ failure provided. The compositions are also suitable for treating and/or preventing COVID-19 and influenza. The compositions and methods employ MG53, which can be in the form of recombinant human MG53. The MG53 may also be administered as a composition that expresses and releases MG53 after in vivo administration of said composition to a subject.